Synthesis,Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells

In this paper, two new iridium (III) complexes, [Ir(ppy)₂(ipbp)](PF₆) (Ir1) (ppy = 2-phenylpyridine, ipbp = 3-(1H-imidazo[4,5-f][1,10]phenanthrolin-2yl)-4H-chromen-4-one) and [Ir(bzq)₂(ipbp)](PF₆) (Ir2) (bzq = benzo[h]quinolone), were synthesized and characterized. The cytotoxicity of the complexes against human colon cancer HCT116 and normal LO2 cells was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. The complexes Ir1 and Ir2 show high cytotoxic efficacy toward HCT116 cells with a low IC₅₀ value of 1.75 ± 0.10 and 6.12 ± 0.2 µM. Interestingly, Ir1 only kills cancer cells, not normal LO2 cells (IC₅₀ > 200 µM). The inhibition of cell proliferation and migration were investigated by multiple tumor spheroid (3D) and wound healing experiments. The cellular uptake was explored under a fluorescence microscope. The intracellular reactive oxygen species (ROS), change of mitochondrial membrane potential, glutathione (GSH) and adenine nucleoside triphosphate (ATP) were studied. Apoptosis and cell cycle arrest were performed by flow cytometry. The results show that the complexes induce early apoptosis and inhibit the cell proliferation at the G0/G1 phase. Additionally, the apoptotic mechanism was researched by Western blot analysis. The results obtained demonstrate that the complexes cause apoptosis in HCT116 cells through ROS-mediated mitochondrial dysfunction and the inhibition of PI3K/AKT signaling pathways.     

含C^N-螯合配体的环戊二烯基铱抗癌配合物

合成、表征了8个半三明治结构环戊二烯基金属铱配合物[（η⁵-Cp^x）Ir（C^N）Cl],其中Cp^x分别为四甲基环戊二烯基（C₅Me₄H）,五甲基环戊二烯基（Cp^*）,四甲基（苯基）环戊二烯基（Cp^xph）,四甲基（联苯）环戊二烯基（Cp^xbiph）,C^N为苯亚甲基甲胺（BIMA）,N-（4-甲氧基苯亚甲基）苯胺（MBIA）。测定了其中3个配合物的单晶结构。所有配合物对Hela人宫颈癌细胞显示出很强的细胞毒性,IC₅₀值为1.7~32.9 μmol·L^-1。经检测Cp^x铱配合物的抗癌活性顺序为Cp^xbiph > Cp^xph > C₅Me₄H > Cp^*。配合物[（η⁵-Cp^xbiph）Ir（BIMA）Cl]（A4）和[（η⁵-Cp^xbiph）Ir（MBIA）Cl]（B4）表现出了最高的抗癌活性,比临床铂类药物顺铂活性高4倍以上。经检测,铱配合物A1~B4不与9-甲基腺嘌呤和9-乙基鸟嘌呤反应,与pBR322 DNA也没有作用,但这些配合物能够作为氢转移催化剂,将辅酶NADH转化为NAD⁺。机理研究表明配合物A4、B4处理Hela细胞时会引起明显的细胞凋亡和细胞周期的变化,并大幅增加细胞内活性氧（ROS）的水平。     

含C^N-螯合配体的环戊二烯基铱抗癌配合物

合成、表征了8个半三明治结构环戊二烯基金属铱配合物[（η⁵-Cp^x）Ir（C^N）Cl],其中Cp^x分别为四甲基环戊二烯基（C₅Me₄H）,五甲基环戊二烯基（Cp^*）,四甲基（苯基）环戊二烯基（Cp^xph）,四甲基（联苯）环戊二烯基（Cp^xbiph）,C^N为苯亚甲基甲胺（BIMA）,N-（4-甲氧基苯亚甲基）苯胺（MBIA）。测定了其中3个配合物的单晶结构。所有配合物对Hela人宫颈癌细胞显示出很强的细胞毒性,IC₅₀值为1.7~32.9 μmol·L^-1。经检测Cp^x铱配合物的抗癌活性顺序为Cp^xbiph > Cp^xph > C₅Me₄H > Cp^*。配合物[（η⁵-Cp^xbiph）Ir（BIMA）Cl] （A4）和[（η⁵-Cp^xbiph）Ir（MBIA）Cl] （B4）表现出了最高的抗癌活性,比临床铂类药物顺铂活性高4倍以上。经检测,铱配合物A1~B4不与9-甲基腺嘌呤和9-乙基鸟嘌呤反应,与pBR322 DNA也没有作用,但这些配合物能够作为氢转移催化剂,将辅酶NADH转化为NAD⁺。机理研究表明IC₅₀浓度的配合物A4、B4处理Hela细胞时会引起明显的细胞凋亡和细胞周期的变化,并大幅增加细胞内活性氧（ROS）的水平。     

Lysosome‐targeted Cyclometalated Iridium (III) Anticancer Complexes Bearing Phosphine‐Sulfonate Ligands

The synthesis, characterization and biological activity of four cyclometalated Ir (III) complexes ( Ir1 ‐ Ir4 ) containing different phosphine‐sulfonate ligands are reported. Most of these complexes showed good activity against A549 cancer cell lines and the human HeLa cervical cell lines. Spectroscopic properties study displays that all four complexes show rich fluorescence with emission maxima in the range of 474–510 nm. Fluorescence property of these complexes provides a tool to investigate the microscopic mechanism by confocal microscopy. Notably, the typical Ir (III) complex Ir4 can specially localize to lysosome, damage it and induce cell death via apoptosis. In addition, Ir4 enters into A549 cancer cells dominantly through energy‐dependent pathway.     

金属钌配合物的抗肿瘤活性及其作用机理

金属配合物在医药领域起着重要的作用,金属钌配合物在抗肿瘤活性研究方面取得了重要的进展.结合本组的研究工作,本文对金属钌配合物在抗肿瘤活性以及抗肿瘤作用机制方面的研究进展进行了综述.     

新型含吡咯亚胺基辅助配体的金属铱(III)配合物的 合成、表征及发光性质

合成了一系列含有吡咯亚胺基为辅助配体的2-苯基吡啶铱配合物[(ppy)2Ir(N^N)] (ppy＝2-苯基吡啶), 通过1H NMR, MS, HRMS和元素分析对配合物结构进行了表征, 并研究了合成配合物的反应条件、紫外吸收光谱、光致发光光谱及铱配合物荧光量子产率. 结果表明, 在无水乙酸钠、二氯甲烷溶液中, 室温反应12 h可获得较高的产率. 通过改变吡咯亚胺类配体中的取代基, 该类配合物在507～606 nm之间具有不同的发光波长, 实现了从绿光到红光的转变. 所有的铱配合物在二氯甲烷溶液(空气中)表现出较高的量子效率(0.25～0.95).     

Cyclometalated Iridium(III) Complexes with Deoxyribose Substituents

Fundamental study of enzymatic nucleoside transport suffers for lack of optical probes that can be tracked noninvasively. Nucleoside transporters are integral membrane glycoproteins that mediate the salvage of nucleosides and their passage across cell membranes. The substrate recognition site is the deoxyribose sugar, often with little distinction among nucleobases. Reported here are nucleoside analogues in which emissive, cyclometalated iridium(III) complexes are “clicked” to C‐1 of deoxyribose in place of canonical nucleobases. The resulting complexes show visible luminescence at room temperature and 77 K with microsecond‐length triplet lifetimes. A representative complex is crystallographically characterized. Transport and luminescence are demonstrated in cultured human carcinoma (KB3‐1) cells.     

pH-Responsive N^C-Cyclometalated Iridium(III) Complexes: Synthesis,Photophysical Properties,Computational Results,and Bioimaging Application

Herein we report four [Ir(N^C)₂(L^L)]ⁿ⁺, n = 0,1 complexes (1–4) containing cyclometallated N^C ligand (N^CH = 1-phenyl-2-(4-(pyridin-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole) and various bidentate L^L ligands (picolinic acid (1), 2,2′-bipyridine (2), [2,2′-bipyridine]-4,4′-dicarboxylic acid (3), and sodium 4,4′,4″,4‴-(1,2-phenylenebis(phosphanetriyl))tetrabenzenesulfonate (4). The N^CH ligand precursor and iridium complexes 1–4 were synthesized in good yield and characterized using chemical analysis, ESI mass spectrometry, and NMR spectroscopy. The solid-state structure of 2 was also determined by XRD analysis. The complexes display moderate to strong phosphorescence in the 550–670 nm range with the quantum yields up to 30% and lifetimes of the excited state up to 60 µs in deoxygenated solution. Emission properties of 1–4 and N^CH are strongly pH-dependent to give considerable variations in excitation and emission profiles accompanied by changes in emission efficiency and dynamics of the excited state. Density functional theory (DFT) and time-dependent density functional theory (TD DFT) calculations made it possible to assign the nature of emissive excited states in both deprotonated and protonated forms of these molecules. The complexes 3 and 4 internalize into living CHO-K1 cells, localize in cytoplasmic vesicles, primarily in lysosomes and acidified endosomes, and demonstrate relatively low toxicity, showing more than 80% cells viability up to the concentration of 10 µM after 24 h incubation. Phosphorescence lifetime imaging microscopy (PLIM) experiments in these cells display lifetime distribution, the conversion of which into pH values using calibration curves gives the magnitudes of this parameter compatible with the physiologically relevant interval of the cell compartments pH.     

Simple Synthesis of Red Iridium(III) Complexes with Sulfur-Contained Four-Membered Ancillary Ligands for OLEDs

Phosphorescent iridium(III) complexes have been widely researched for the fabrication of efficient organic light-emitting diodes (OLEDs). In this work, three red Ir(III) complexes named Ir-1, Ir-2, and Ir-3, with Ir-S-C-S four-membered framework rings, were synthesized efficiently at room temperature within 5 min using sulfur-containing ancillary ligands with electron-donating groups of 9,10-dihydro-9,9-dimethylacridine, phenoxazine, and phenothiazine, respectively. Due to the same main ligand of 4-(4-(trifluoromethyl)phenyl)quinazoline, all Ir(III) complexes showed similar photoluminescence emissions at 622, 619, and 622 nm with phosphorescence quantum yields of 35.4%, 50.4%, and 52.8%, respectively. OLEDs employing these complexes as emitters with the structure of ITO (indium tin oxide)/HAT-CN (dipyra-zino[2,3-f,2′,3′-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile, 5 nm)/TAPC (4,4′-cyclohexylidenebis[N,N-bis-(4-methylphenyl)aniline], 40 nm)/TCTA (4,4″,4″-tris(carbazol-9-yl)triphenylamine, 10 nm)/Ir(III) complex (10 wt%): 2,6DCzPPy (2,6-bis-(3-(carbazol-9-yl)phenyl)pyridine, 10 nm)/TmPyPB (1,3,5-tri(mpyrid-3-yl-phenyl)benzene, 50 nm)/LiF (1 nm)/Al (100 nm) achieved good performance. In particular, the device based on complex Ir-3 with the phenothiazine unit showed the best performance with a maximum brightness of 22,480 cd m⁻², a maximum current efficiency of 23.71 cd A⁻¹, and a maximum external quantum efficiency of 18.1%. The research results suggest the Ir(III) complexes with a four-membered ring Ir-S-C-S backbone provide ideas for the rapid preparation of Ir(III) complexes for OLEDs.     

Mechanism‐Guided Design and Synthesis of a Mitochondria‐Targeting Artemisinin Analogue with Enhanced Anticancer Activity

Understanding the mechanism of action (MOA) of bioactive natural products will guide endeavor to improve their cellular activities. Artemisinin and its derivatives inhibit cancer cell proliferation, yet with much lower efficiencies than their roles in killing malaria parasites. To improve their efficacies on cancer cells, we studied the MOA of artemisinin using chemical proteomics and found that free heme could directly activate artemisinin. We then designed and synthesized a derivative, ART‐TPP, which is capable of targeting the drug to mitochondria where free heme is synthesized. Remarkably, ART‐TPP exerted more potent inhibition than its parent compound to cancer cells. A clickable probe ART‐TPP‐Alk was also employed to confirm that the attachment of the TPP group could label more mitochondrial proteins than that for the ART derivative without TPP (AP1). This work shows the importance of MOA study, which enables us to optimize the design of natural drug analogues to improve their biological activities.     

Emissive Iridium(III) Complexes with Phosphorous‐Containing Ancillary

Ir(III) metal complexes and related emitters bearing all kind of cyclometalated chromophoric chelates and non‐chromophoric ancillary are extensively studied during the past three decades. Many of them have been found to display bright room temperature phosphorescence from triplet excited states in both solution and solid states, offering a possible application in contemporary optoelectronic technologies, including organic light emitting diodes, electrochemiluminescence, biological imaging and chemical sensing. Among reported materials, there are Ir(III) complexes with at least one phosphorus (P)‐containing ligand and/or ancillary chelate, together with cyclometalates or equivalents that are in control of the actual emission energy. Particularly, possession of P‐based donor can lead to divergent structural and photophysical properties compared to the traditional designs. This review aims to provide a literature overview as well as the authors’ personal account to the development of relevant Ir(III) based phosphors bearing these P‐donors. To the readers’ convenience, the contents are subdivided into six sessions, according to whether or not they are charge natural, or with mono‐ or dianionic electronic character, and in accordance to their divergent bonding modes, i. e. monodentate, bidentate and tripodal coordination. In many cases, the P‐based ancillaries offer an easy accessible route to the formation of efficient sky‐blue and true‐blue emitters due to their π‐accepting property, together with enlarged emission energy gap and destabilized upper lying quenching state.     

基于苯基修饰策略的新型可溶液加工红光铱配合物的设计、合成及电致发光性能研究

利用向环金属配体的C-Ir键的对位进行苯基取代这一结构修饰策略,成功合成了两种新型铱（III）配合物（3PhNbt）₂Ir（acac）和（3OMePhNbt）₂Ir（acac）.相较其橙光发射的母体化合物（Nbt）₂Ir（acac）,两个目标化合物的抗结晶性、非晶态热稳定性及溶解性均有显著提高,其磷光发射带也发生了5~10 nm的红移.以（3PhNbt）₂Ir（acac）和（3OMePhNbt）₂Ir（acac）为发光客体材料所制备的单层溶液加工电致红光器件,其最大发光亮度分别为1830 cd·m^-2和6630 cd·m^-2,最大电流效率分别为2.4 cd·A^-1和8.7 cd·A^-1,CIE1931色坐标分别为（0.61,0.39）和（0.62,0.38）.相比之下,以母体化合物（Nbt）₂Ir（acac）为发光客体材料所制备的参比器件,其最大发光亮度则为1620 cd·m^-2,最大电流效率仅为1.5 cd·A^-1,CIE1931色坐标为（0.59,0.41）.上述研究结果表明：向C-Ir键对位进行苯基修饰可以在提高铱（III）配合物的可溶液加工性能的同时,获得更为红移的电致发光波长,是一种简单而有效的红光铱（III）配合物的分子设计策略.     

Protein Staining Agents from Cationic and Neutral Luminescent Iridium(III) Complexes

Seven luminescent iridium(III) complexes were prepared to investigate the relationships between chemical structures and properties of protein staining. For the first time, the effect of the main ligand, the π conjugation effect of the ancillary ligand, and the charge effect of organometallic complexes on protein staining has been revealed. Most importantly, this study gives the first experimental evidence of the potential applications of charge‐neutral organometallic complexes in protein staining, which could open an avenue of exploiting novel protein staining agents in the future.     

Targeting G-Rich DNA Structures with Photoreactive Bis-Cyclometallated Iridium(III) Complexes

The synthesis and characterisation of three novel iridium(III) bis-cyclometallated complexes is reported. Their photophysics have been fully characterised by classical methods and revealed charge-transfer (CT) and ligand-centred (LC) transitions. Their ability to selectively interact with G-quadruplex telomeric DNA over duplex DNA has been studied by circular dichroism (CD), bio-layer interferometry (BLI) and surface plasmon resonance (SPR) analyses. Interestingly, one of the complexes was able to promote photoinduced electron transfer (PET) with the guanine DNA base, which in turn led to oxidative damage (such as the formation of 8-oxoguanine) to the telomeric sequence. To the best of our knowledge, this is the first study of highly photo-oxidising bis-cyclometallated iridium(III) complexes with G-quadruplex telomeric DNA.     

Modification of Luminescent Iridium(III) Polypyridine Complexes with Discrete Poly(ethylene glycol) (PEG) Pendants: Synthesis,Emissive Behavior,Intracellular Uptake,and PEGylation Properties

We report the synthesis, characterization, and photophysical properties of a new class of luminescent cyclometalated iridium(III) polypyridine poly(ethylene glycol) (PEG) complexes [Ir(N^C)₂(N^N)](PF₆) (HN^C=Hppy (2‐phenylpyridine), N^N=bpy? CONH? PEG1 (bpy=2,2′‐bipyridine; 1 a ), bpy? CONH? PEG3 ( 1 b ); HN^C=Hpq (2‐phenylquinoline), N^N=bpy? CONH? PEG1 ( 2 a ), bpy? CONH? PEG3 ( 2 b ); HN^C=Hpba (4‐(2‐pyridyl)benzaldehyde), N^N=bpy? CONH? PEG1 ( 3 )) and their PEG‐free counterparts (N^N=bpy? CONH? Et, HN^C=Hppy ( 1 c ); HN^C=Hpq ( 2 c )). The cytotoxicity and cellular uptake of these complexes have been investigated by the MTT assay, ICPMS, laser‐scanning confocal microscopy, and flow cytometry. The results showed that the complexes supported by the water‐soluble PEG can act as biological probes and labels with considerably reduced cytotoxicity. Because the aldehyde groups of complex 3 are reactive toward primary amines, the complex has been utilized as the first luminescent PEGylation reagent. Bovine serum albumin (BSA) and poly(ethyleneimine) (PEI) have been PEGylated with this complex, and the resulting conjugates have been isolated, purified, and their photophysical properties studied. The DNA‐binding and gene‐delivery properties of the luminescent PEI conjugate 3 ‐PEI have also been investigated.     

Iridium(III) Complexes with Sulfonyl and Fluorine Substituents: Synthesis,Stereochemistry and Effect of Functionalisation on their Photophysical Properties

The synthesis and photophysical and electrochemical characterisation of new heteroleptic iridium complexes with electron‐withdrawing sulfonyl groups and fluorine atoms bound to phenylpyridine ligands are reported. The emission energy of these materials strongly depends on the position of the sulfonyl groups and on the number of fluorine substituents. A 90 nm wide tuning range of photoluminescence from the blue‐green (λ_em=468 nm) of iridium(III)bis[2‐(4′‐benzylsulfonyl)phenylpyridinato‐N,C2′][3‐(pentafluorophenyl)‐pyridin‐2‐yl‐1,2,4‐triazolate] to the orange (λ_em=558 nm) of iridium(III)bis[2‐(3′‐benzylsulfonyl)phenylpyridinato‐N,C2′](2,4‐decanedionate) has been achieved. Emission quantum yields ranging from 47 to 71 % have also been found for degassed solutions of the complexes, and a surprisingly high value of 16 % was recorded for iridium(III)bis[2‐(5′‐benzylsulfonyl‐3′,6′‐difluoro)phenylpyridinato‐N,C2′](2,4‐decanedionate) in air‐equilibrated dichloromethane. A unusual stereochemistry of the benzylsulfonyl‐substituted dimer and heteroleptic complexes has been detected by ¹H NMR spectroscopy, and is characterised by the mutual cis disposition of the pyridyl nitrogen atoms of the phenylpyridine ligands, which differs from the most common trans arrangement reported in the literature.     

Rational Design of Cyclometalated Iridium(III) Complexes for Three-Photon Phosphorescence Bioimaging

Compared to 2PE (two-photon excitation) microscopy, 3PE microscopy has superior spatial resolution, deeper tissue penetration, and less defocused interference. The design of suitable agents with a large Stokes shift, good three-photon absorption (3PA), subcellular targeting, and fluorescence lifetime imaging (FLIM) properties, is challenging. Now, two Ir^III complexes (3PAIr1 and 3PAIr2) were developed as efficient three-photon phosphorescence (3PP) agents. Calculations reveal that the introduction of a new group to the molecular scaffold confers a quadruple promotion in three-photon transition probability. Confocal and lifetime imaging of mitochondria using Ir^III complexes as 3PP agents is shown. The complexes exhibit low working concentration (50 nm ), fast uptake (5 min), and low threshold for three-photon excitation power (0.5 mW at 980 nm). The impressive tissue penetration depth (ca. 450 μm) allowed the 3D imaging and reconstruction of brain vasculature from a living specimen.     

Cyclometalated Iridium(III) and Rhodium(III) Complexes Containing Naphthyridine Ligands: Synthesis,Characterization and Biological Studies

The synthesis, crystal structure, and biological activity of new bis‐cyclometalated compounds [M(ptpy)₂(4‐chloro‐2‐methyl‐1,8‐naphthyridine)]PF₆ [M = Rh ( 1 ); M = Ir ( 2 ); ptpy = 2‐(p‐tolyl)pyridinato] and [M(ptpy)₂(2‐methyl‐1,8‐naphthyridine)]PF₆ [M = Rh ( 3 ); M = Ir ( 4 )] are described. The new compounds were prepared by the reaction of [{M(μ‐Cl)(ptpy)₂}₂] (M = Rh, Ir) with the corresponding naphthyridine ligands. The molecular structures of compounds 1 , 3 , and 4 were confirmed by single‐crystal X‐ray diffraction studies.     

Unambiguous Intracellular Localization and Quantification of a Potent Iridium Anticancer Compound by Correlative 3D Cryo X‐Ray Imaging

The iridium half‐sandwich complex [Ir(η⁵:κ¹‐C₅Me₄CH₂py)(2‐phenylpyridine)]PF₆ is highly cytotoxic: 15–250× more potent than clinically used cisplatin in several cancer cell lines. We have developed a correlative 3D cryo X‐ray imaging approach to specifically localize and quantify iridium within the whole hydrated cell at nanometer resolution. By means of cryo soft X‐ray tomography (cryo‐SXT), which provides the cellular ultrastructure at 50 nm resolution, and cryo hard X‐ray fluorescence tomography (cryo‐XRF), which provides the elemental sensitivity with a 70 nm step size, we have located the iridium anticancer agent exclusively in the mitochondria. Our methodology provides unique information on the intracellular fate of the metallodrug, without chemical fixation, labeling, or mechanical manipulation of the cells. This cryo‐3D correlative imaging method can be applied to a number of biochemical processes for specific elemental localization within the native cellular landscape.     

Achieving High-Performance Pure-Red Electrophosphorescent Iridium(III) Complexes Based on Optimizing Ancillary Ligands

Two new iridium(III) complexes were synthesized by introducing two trifluoromethyl groups into an ancillary ligand to develop pure-red emitters for organic light-emitting diodes (OLEDs). The electron-donating ability of the ancillary ligands is suppressed, owing to the electron-withdrawing nature of trifluoromethyl groups, which can reduce the HOMO energy levels compared with those of compounds without trifluoromethyl groups. However, the introduction of trifluoromethyl groups into the ancillary ligand has little impact on the LUMO energy levels. Therefore, a well-tuned, pure-red, excited-state energy was achieved by regulating the relative energy level between the HOMO and LUMO. OLEDs with these complexes as emitters showed high external quantum efficiencies (EQEs) of 26 % and realized high EQEs of about 25 % and fairly low driving voltages of 3.3–3.6 V for practical luminance of 1000 cd m⁻², as well as excellent Commission Internationale de L'Eclairage (CIE) coordinates of (0.66, 0.33) and (0.67, 0.33); thus, this demonstrates the successful molecular design strategy by modifying the electron-donating ability of ancillary ligand.